# clm_704A9CC6C45D

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_revenue  
value: 2,857,200,000 United States dollar  
valid_from: 2022-06-30  
valid_to: 2022-09-30  
published: 2022-08-03  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_41EB8CF3FDDA  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly revenue: 2,857,200,000 United States dollar", as of 2022-06-30 (until 2022-09-30). Claim clm_704A9CC6C45D, https://asof.is/claim/clm_704A9CC6C45D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q2 FY2022, filed 2022-08-03  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422022000023/0001804220-22-000023-index.htm (primary, SEC EDGAR 10-Q Q2 FY2022, published 2022-08-03)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_revenue | 2,965,100,000 United States dollar | valid 2022-03-31 to 2022-06-30 | conf 0.95 | superseded | superseded_by [clm_704A9CC6C45D](/claim/clm_704A9CC6C45D.md) | [clm_DA35C89878EA](/claim/clm_DA35C89878EA.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.